Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application

被引:154
|
作者
von Bergwelt-Baildon, MS
Vonderheide, RH
Maecker, B
Hirano, N
Anderson, KS
Butler, MO
Xia, ZN
Zeng, WY
Wucherpfennig, KW
Nadler, LM
Schultze, JL
机构
[1] Univ Cologne, Dept Hematol Oncol, Tumor Immunol Lab, D-50924 Cologne, Germany
[2] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V99.9.3319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD40 engagement is the major signal that induces B cells to efficiently present antigen to T cells. We previously demonstrated that human peripheral blood-derived CD40-activated B cells (CD4D-B cells) function as antigen-presenting cells (APCs). Here, we have established a culture system to generate these APCs under clinically applicable conditions using guanylic acid-grade soluble trimeric CD40 ligand. To monitor APC function and antigen loading for these cells, simple and efficient quality control assays have been developed. Using this approach, we demonstrate that CD40-B cells from healthy donors and cancer patients are fully functional and equally expanded in long-term cultures. These B cells boost robust memory T-cell responses, but more importantly, they also prime naive T-cell responses against neoantigens ex vivo. CD40-B cells overcome current obstacles, such as the difficulty of isolation, generation, and long-term expansion observed with other APCs. Therefore, they are an excellent source of professional APCs for immune assessment, antigen discovery, and antigen-specific immunotherapy. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3319 / 3325
页数:7
相关论文
共 50 条
  • [21] RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma
    N J Mason
    C M Coughlin
    B Overley
    J N Cohen
    E L Mitchell
    T A Colligon
    C A Clifford
    A Zurbriggen
    K U Sorenmo
    R H Vonderheide
    Gene Therapy, 2008, 15 : 955 - 965
  • [22] THE HUMAN ANTIMURINE XENOGENEIC CYTOTOXIC RESPONSE .2. ACTIVATED MURINE ANTIGEN-PRESENTING CELLS DIRECTLY STIMULATE HUMAN T-HELPER CELLS
    LUCAS, PJ
    BARE, CV
    GRESS, RE
    JOURNAL OF IMMUNOLOGY, 1995, 154 (08): : 3761 - 3770
  • [23] GENERATION OF A NOVEL CD8+ CYTOTOXIC T-LYMPHOCYTE THAT REQUIRES SOLUBLE FACTOR TO LYSE AUTOLOGOUS ANTIGEN-PRESENTING CELLS
    YOSHIZUMI, H
    KAMIKAWAJI, N
    NISHIMURA, Y
    SASAZUKI, T
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) : 3173 - 3180
  • [24] CD40L is transferred to antigen-presenting B cells during delivery of T-cell help
    Gardell, Jennifer L.
    Parker, David C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (01) : 41 - 50
  • [25] Human Lung Fibroblasts Are Antigen-Presenting Cells That Activate Bacteria-Specific Autologous Memory Cd4+T Cells
    Hutton, A. J.
    Staples, K. J.
    Wilkinson, T. M. A.
    Warner, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [26] Co-stimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells
    Watanabe, Masashi
    Fujihara, Chiharu
    Radtke, Andrea J.
    Chiang, Y. Jeffrey
    Bhatia, Sumeena
    Germain, Ronald N.
    Hodes, Richard J.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (09): : 2795 - 2810
  • [27] Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells
    Tu, Wenwei
    Lau, Yu-Lung
    Zheng, Jian
    Liu, Yinping
    Chan, Ping-Lung
    Mao, Huawei
    Dionis, Kira
    Schneider, Pascal
    Lewis, David B.
    BLOOD, 2008, 112 (06) : 2554 - 2562
  • [28] CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells
    Lapointe, R
    Bellemare-Pelletier, A
    Housseau, F
    Thibodeau, J
    Hwu, P
    CANCER RESEARCH, 2003, 63 (11) : 2836 - 2843
  • [29] RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells
    Shen, S. N.
    Xu, Z.
    Qian, X. P.
    Ding, Y. T.
    Yu, L. X.
    Liu, B. R.
    EUROPEAN JOURNAL OF CANCER CARE, 2008, 17 (04) : 404 - 411
  • [30] Ex vivo induction of viral antigen-specific CD8+ T cell responses using mRNA-electroporated CD40-activated B cells
    Van den Bosch, GA
    Ponsaerts, P
    Nijs, G
    Lenjou, M
    Vanham, G
    Van Bockstaele, DR
    Berneman, ZN
    Van Tendeloo, VFI
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (03): : 458 - 467